103
Participants
Start Date
February 1, 2024
Primary Completion Date
September 30, 2024
Study Completion Date
December 31, 2024
Asthma Symptom Monitoring online tools
All participants will be provided access to the Asthma Symptom Monitoring tools and 3/4's will be randomized to one of the other three arms above
Inhaled Steroids
participants will use either a combination of budesonide/formoterol or mometasone/formoterol as both controller and rescue therapy or a stand alone inhaled steroid (beclomethasone, budesonide, fluticasone, mometasone, ciclesodine) of their choice with their current reliever therapy or be converted to budesonide/albuterol as rescue therapy
Azithromycin Pill
Participants will take 500mg of azithromycin three times a week or 10mg/kg if under 50Kg which may be reduced to 250mg/Kg for side effects
DARTNet Insitute, Aurora
Lead Sponsor
Collaborators (1)
Penn State University
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
University of Colorado, Denver
OTHER
RAND
OTHER
University of Washington
OTHER
Rutgers University
OTHER
University of North Carolina
OTHER
Brigham and Women's Hospital
OTHER
Reliant Medical Group
OTHER
Kelsey Research Foundation
OTHER
Wake Forest University Health Sciences
OTHER
DARTNet Institute
OTHER_GOV